Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4088678
Max Phase: Preclinical
Molecular Formula: C28H28N4OS
Molecular Weight: 468.63
Molecule Type: Small molecule
Associated Items:
ID: ALA4088678
Max Phase: Preclinical
Molecular Formula: C28H28N4OS
Molecular Weight: 468.63
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc(-c2ccc(-n3c(=O)c4c5c(sc4n4cnnc34)CC(C(C)(C)C)CC5)cc2)cc1
Standard InChI: InChI=1S/C28H28N4OS/c1-17-5-7-18(8-6-17)19-9-12-21(13-10-19)32-25(33)24-22-14-11-20(28(2,3)4)15-23(22)34-26(24)31-16-29-30-27(31)32/h5-10,12-13,16,20H,11,14-15H2,1-4H3
Standard InChI Key: WDPVSCDKELCFCV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 468.63 | Molecular Weight (Monoisotopic): 468.1984 | AlogP: 6.22 | #Rotatable Bonds: 2 |
Polar Surface Area: 52.19 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 7.11 | CX LogD: 7.11 |
Aromatic Rings: 5 | Heavy Atoms: 34 | QED Weighted: 0.31 | Np Likeness Score: -1.49 |
1. Kumar Biswas B, Malpani YR, Ha N, Kwon DH, Soo Shin J, Kim HS, Kim C, Bong Han S, Lee CK, Jung YS.. (2017) Enterovirus inhibitory activity of C-8-tert-butyl substituted 4-aryl-6,7,8,9-tetrahydrobenzo[4,5]thieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-ones., 27 (15): [PMID:28587824] [10.1016/j.bmcl.2017.05.030] |
Source(1):